nach oben

Erschienen in:

2017 | OriginalPaper | Buchkapitel

Studies on Arsenic and Human Health

verfasst von : Soumya Chatterjee, Sibnarayan Datta, Dharmendra K. Gupta

Erschienen in: Arsenic Contamination in the Environment

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Arsenic is a widespread element in the environment and it is highly toxic to human health. It is a Group A human carcinogen. Chronic arsenic exposure causes various dreaded ailments including cancer in skin, lung, and bladder, as well as in other organs. Arsenic induces epigenetic alterations and aberrant DNA methylation, causing inherent damage to cells. Addressing the issue at molecular level, researchers are interested to understand the distribution, metabolism, and potential modes of actions of inorganic arsenic (iAs). Paradoxically, apart from poisoning, arsenic has long been in medicinal use for treatment of various diseases like asthma, syphilis, trypanosomiasis, lichen planus, verruca plenum, tropical eosinophilia, and psoriasis. It is also a potentially important chemotherapeutic agent against acute promyelocytic leukemia and can help in activating the cytotoxic effects of DNA damaging chemotherapeutics. To extend precise therapeutic strategies against arsenic, integrated study on environmental monitoring, health surveillance, exposure data, individual risk characterization, and human biomarkers are required which will be able to provide mechanistic insight into the pathogenesis of disease processes.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Arsenic: Source, Occurrence, Cycle, and Detection

Nächstes Kapitel Epigenetics in Arsenic Toxicity: Mechanistic Response, Alterations, and Regulations

Ades L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S, Recher C, Thomas X, Rayon C, Castaigne S, Tournilhac O, de Botton S, Ifrah N, Cahn JY, Solary E, Gardin C, Fegeux N, Bordessoule D, Ferrant A, Meyer-Monard S, Vey N, Dombret H, Degos L, Chevret S, Fenaux P, European APL Group (2010) Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood 115:1690–1696CrossRef

Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, Ekström EC, Vahter M, Raqib R (2011) Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect 119:258–264CrossRef

Andrew AS, Burgess JL, Meza MM, Demidenko E, Waugh MG, Hamilton JW, Karagas MR (2006) Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect 114:1193–1198CrossRef

Andrew AS, Mason RA, Memoli V, Duell EJ (2009) Arsenic activates EGFR pathway signalling in the lung. Toxicol Sci 109:350–357CrossRef

Argos M, Pierce BL, Chen Y, Parvez F, Islam T, Ahmed A, Hasan R, Hasan K, Sarwar G, Levy D, Slavkovich V, Graziano JH, Rathouz PJ, Ahsan H (2011) A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Amer J Epidemiol 174:185–194CrossRef

ATSDR-Agency for Toxic Substances and Disease Registry (2007) Toxicological profile for Arsenic. Public Health Service (US DHHS, http://www.atsdr.cdc.gov/toxprofiles/tp2-c3.pdf)

Basu A, Som A, Ghoshal S, Mondal L, Chaubey RC, Bhilwade HN, Rahman MM, Giri AK (2005) Assessment of DNA damage in peripheral blood lymphocytes of individuals susceptible to arsenic induced toxicity in West Bengal, India. Toxicol Lett 159:100–112CrossRef

Beezhold K, Liu J, Kan H, Meighan T, Castranova V, Shi X, Chen F (2011) miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol Sci 123:411–420CrossRef

Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon MF (1973) Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood 41:489–496

Bhattacharjee Y (2007) A sluggish response to humanity’s biggest mass poisoning. Science 315:1659–1661CrossRef

Buchanan WD (1962) Toxicity of arsenic compounds. Elsevier, Amsterdam, pp 1–13

Caroli S (1996) Element speciation in bioinorganic chemistry. Wiley, New York.

Cebrian ME, Albores A, Aguilar M, Blakely E (1983) Chronic arsenic poisoning in the north of Mexico. Hum Toxicol 2:121–133CrossRef

Chakraborti D, Rahman MM, Paul K, Sengupta MK, Chowdhury UK, Lodh D, Chanda CR, Saha KC, Mukherjee SC (2002) Arsenic calamity in India and Bangladesh sub-continent-whom to blame? Talanta 58:3–22CrossRef

Chakraborty AK, Saha KC (1987) Arsenical dermatosis from tube-well water in West Bengal. Ind J Med Res 85:326–334

Challenger F (1945) Biological methylation. Chem Rev 36:315–361CrossRef

Challenger F (1951) Biological methylation. Adv Enzymol 12:432–491

Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D (2006) DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 89:431–437CrossRef

Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, Chen SY, Wu M, Lai MS (2007) Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 222:298–304CrossRef

Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Wang YH, Chen CJ (2010) Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan. Cancer Epidemiol Biomark Prev 19:101–110CrossRef

Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z (1997) Use of arsenic trioxide (As₂O₃) in the treatment of acute promyelocytic leukemia (APL), I: As₂O₃ exerts dose dependent dual effects on APL cells. Blood 89:3345–3353

Chen SJ, Zhou GB, Zhang XW, Mao JH, de The H, Chen Z (2011) From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood 117:6425–6437CrossRef

Chen JW, Wang SL, Wang YH, Sun CW, Huang YL, Chen CJ, Li WF (2012) Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan. Chemosphere 88:432–438CrossRef

Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, Ahmed A, Argos M, Islam T, Rakibuz-Zaman M, Hasan R, Sarwar G, Levy D, Graziano J, Ahsan H (2013) A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect 121:832–838CrossRef

Cheng HY, Li P, David M, Smithgall TE, Feng L, Lieberman MW (2004) Arsenic inhibition of the JAK-STAT pathway. Oncogene 23:3603–3612CrossRef

Chervona Y, Arita A, Costa M (2012) Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics 4:619–627CrossRef

Chetia M, Chatterjee S, Banerjee S, Nath MJ, Singh L, Srivastava RB, Sarma HP (2011) Groundwater arsenic contamination in Brahmaputra river basin: a water quality assessment in Golaghat (Assam), India. Environ Monit Assess 173:371–385CrossRef

Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ (1997) Dose response relationship between prevalence of cardiovascular disease and ingested inorganic arsenic. Stroke 28:1717–1723CrossRef

Chowdhury UK, Rahman MM, Sengupta MK, Lodh D, Chanda CR, Roy S, Quamruzzaman Q, Tokunage H, Ando M, Chakraborti D (2003) Pattern of excretion of arsenic compounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of children compared to adults from an arsenic exposed area in Bangladesh. J Environ Sci Health A Tox Hazard Subst Environ Eng 38:87–113CrossRef

Creutzig U, Zimmermann M, Dworzak M, Urban C, Henze G, Kremens B, Lakomek M, Bourquin JP, Stary J, Reinhardt D (2010) Favourable outcome of patients with childhood acute promyelocytic leukemia after treatment with reduced cumulative anthracycline doses. Bra J Haematol 149:399–409CrossRef

Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S (2006) Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in a/J mice. Toxicol Sci 91:372–381CrossRef

Cui Y, Han Z, Hu Y, Song G, Hao C, Xia H, Ma X (2012) MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1. J Cell Physiol 227:772–783CrossRef

Cullen WR, Reimer KJ (1989) Arsenic speciation in the environment. Chem Rev 89:713CrossRef

Cullen WR (2008) The sociochemistry of an element. Is arsenic an aphrodisiac? RSC Publishing, Cambridge, pp 130–214

Datta DV (1976) Arsenic and non-cirrhotic portal hypertension. Lancet 1:433CrossRef

Datta DV, Mitra SK, Chhuttani PN, Chakravarti RN (1979) Chronic oral arsenic intoxication as a possible etiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut 20:378–384CrossRef

De BK, Majumdar D, Sen S, Guru S, Kundu S (2004) Pulmonary involvement in chronic arsenic poisoning from drinking contaminated ground-water. J Assoc Physician Ind 52:395–400

de The H, Chen Z (2010) Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer 10:775–783CrossRef

Del Razo L, García-Vargas G, Valenzuela OL, Castellanos EH, Sánchez-Peña LC, Currier JM, Drobná Z, Loomis D, Stýblo M (2011) Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ Health 10:73–84CrossRef

Dilda PJ, Hogg PJ (2007) Arsenical-based cancer drugs. Cancer Treat Rev 33:542–564CrossRef

Dong J, Su SY (2009) The association between arsenic and children’s intelligence: a meta-analysis. Biol Trace Elem Res 103:88–93CrossRef

Dong Z (2002) The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ Health Perspect 5:757–759CrossRef

Douer D, Tallman MS (2005) Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 23:2396–2410CrossRef

Drobna Z, Styblo M, Thomas DJ (2009) An overview of arsenic metabolism and toxicity. Overview of arsenic metabolism and toxicity. Curr Protoc Toxicol 42:4311–4316

Ebert F, Weiss A, Bultemeyer M, Hamann I, Hartwig A, Schwerdtle T (2011) Arsenicals affect base excision repair by several mechanisms. Mutat Res 715:32–41CrossRef

EFSA (European Food Safety Authority) (2009) Scientific opinion on arsenic in food. EFSA J 7:60–71

Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH (1994) Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev 16:184–209CrossRef

Faita F, Cori L, Bianchi F, Andreassi MG (2013) Arsenic-induced genotoxicity and genetic susceptibility to arsenic-related pathologies. Int J Environ Res Public Health 10:1527–1546CrossRef

Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51:257–281CrossRef

Forkner CE, McNAIR Scott TF (1931) Arsenic as a therapeutic agent in chronic myelogenous leukemia: preliminary report. JAMA 97:3–5CrossRef

Fujihara J, Soejima M, Yasuda T, Koda Y, Kunito T, Iwata H, Tanabe S, Takeshita H (2011) Polymorphic trial in oxidative damage of arsenic exposed Vietnamese. Toxicol Appl Pharmacol 256:174–178CrossRef

Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, Parvez F, Levy D, Factor-Litvak P, Graziano JH (2005) Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113:1683–1688CrossRef

Gao N, Shen L, Zhang Z, Leonard SS, He H, Zhang XG, Shi X, Jiang BH (2004) Arsenite induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol Cell Biochem 255:33–45CrossRef

Garai R, Chakraborty AK, Dey SB, Saha KC (1984) Chronic arsenic poisoning from tube well water. J Indian Med Assoc 82:34–35

Gebel TW (2002) Arsenic methylation is a process of detoxification through accelerated excretion. Int J Hyg Environ Health 205:505–508CrossRef

Gibb H, Haver C, Gaylor D, Ramasamy S, Lee JS, Lobdell D, Wade T, Chen C, White P, Sams R (2011) Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic. Environ Health Perspect 119:284–290CrossRef

Gong G, Hargrave KA, Hobson V, Spallholz J, Boylan M, Lefforge D, O'Bryant SE (2011) Low-level groundwater arsenic exposure impacts cognition: a project FRONTIER study. J Environ Health 74:16–22

Gong G, O’Bryant SE (2012) Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties. Environ Res 113:52–57CrossRef

Goodman L, Gilman A (1942) The pharmacology basis of therapeutics. MacMillan company, New York

Gordon JJ, Quastel GH (1948) Effect of organic arsenicals on enzyme system. Biochem J 42:337–350CrossRef

Guha Mazumder DN (2000) Diagnosis and treatment of chronic arsenic poisoning (Downloaded from: http://www.who.int/water_sanitation_health/dwq/arsenicun4.pdf)

Guha Mazumder DN (2007) Arsenic and non-malignant lung disease. J Environ Sci Health 42:1859–1868CrossRef

Guha Mazumder DN (2008) Chronic arsenic toxicity and human health. Ind J Med Res 128:436–447

Guha Mazumder DN, Chakraborty AK, Ghose A, Gupta JD, Chakraborty DP, Dey SB, Chattopadhyay N (1988) Chronic arsenic toxicity from drinking tube-well water in rural West Bengal. Bull World Health Organ 66:499–506

Guha Mazumder DN, Das Gupta J, Santra A, Pal A, Ghose A, Sarkar S (1998) Chronic arsenic toxicity in West Bengal—The worst calamity in the world. J Ind Med Assoc 96:4–7

Guha Mazumder DN, Steinmaus C, Bhattacharya P, von Ehrenstein OS, Ghosh N, Gotway M, Sil A, Balmes JR, Haque R, Hira-Smith MM, Smith AH (2005) Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology 16:760–765CrossRef

Gurr JR, Yih LH, Samikkannu T, Bau DT, Lin SY, Jan KY (2003) Nitric oxide production by arsenite. Mut Res 533:173–182CrossRef

Halliwell B (2007) Oxidative stress and cancer: have we moved forward? Biochem J 401:1–11CrossRef

Hamadani JD, Tofail F, Nermell B, Gardner R, Shiraji S, Bottai M, Arifeen SE, Huda SN, Vahter M (2011) Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: a population-based cohort study. Int J Epidemiol 40:1593–1604CrossRef

Hayakawa T, Kobayashi Y, Cui X, Hirano S (2005) A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79:183–191CrossRef

Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ (2009) Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 117:1718–1723CrossRef

Hillestad LK (1957) Acute promyelocytic leukemia. Acta Med Scand 159:189–194CrossRef

Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE (1996) Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 104:620–628CrossRef

Hu J, Liu YF, Wu CF, Xu F, Shen ZX, Zhu YM, Li JM, Tang W, Zhao WL, Wu W, Sun HP, Chen QS, Chen B, Zhou GB, Zelent A, Waxman S, Wang ZY, Chen SJ, Chen Z (2009) Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A 106:3342–3347CrossRef

Huang B, Wang Y (1993) Thousand formulas and thousand herbs of traditional Chinese medicine. Heilongjiang Education Press, Harbin

Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567–572

Huang Y, Zhang J, McHenry KT, Kim MM, Zeng W, Lopez-Pajares V, Dibble CC, Mizgerd JP, Yuan ZM (2008b) Induction of cytoplasmic accumulation of p 53:a mechanism for low levels of arsenic exposure to predispose cells for malignant transformation. Cancer Res 68:9131–9136CrossRef

Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, Hsu LI, Chen CJ (2008a) Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 19:829–839CrossRef

Hubaux R, Becker-Santos DD, Enfield KSS, Rowbotham D, Lam S, Lam WL, Martinez VD (2013) Molecular features in arsenic-induced lung tumors. Mol Cancer 12:20CrossRef

Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ (2011) Arsenic exposure and toxicology: a historical perspective. Toxicol Sci 123:305–332CrossRef

IARC (2004) Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. IARC Monogr Eval Carcino Risks Hum 84:269–477

IARC (International Agency for Research on Cancer monographs on the evaluation of carcinogenic risks to humans) (2012) Arsenic, metals, fibers, and dusts (Vol 100C) A review of human carcinogens; http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C.pdf. Accessed April 2016

Intarasunanont P, Navasumrit P, Woraprasit S, Chaisatra K, Suk WA, Mahidol C, Ruchirawat M (2012) Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health 11:31CrossRef

Islam R, Khan I, Hassan SN, McEvoy M, D'Este C, Attia J, Peel R, Sultana M, Akter S, Milton AH (2012) Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh. Environ Health 11:38CrossRef

Iyer S, Sengupta C, Velumani A (2016) Blood arsenic: pan-India prevalence. Clin Chim Acta 455:99–101CrossRef

Jensen TJ, Wozniak RJ, Eblin KE, Wnek SM, Gandolfi AJ, Futscher BW (2009) Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol 235:39–46CrossRef

Jha AN, Noditi M, Nilsson R, Natarajan AT (1992) Genotoxic effects of sodium arsenite on human cells. Mutat Res 284:215–221CrossRef

Jolliffe DM (1993) A history of the use of arsenicals in man. J Roy Soc Med 86:287–289

Jovanovic D, Rasic-Milutinovic Z, Paunovic K, Jakovljevic B, Plavsic S, Milosevic J (2013) Low levels of arsenic in drinking water and type 2 diabetes in middle Banat region, Serbia. Int J Hyg Environ Health 216:50–55CrossRef

Kapaj S, Peterson H, Liber K, Bhattacharya P (2006) Human health effects from chronic arsenic poisoning—a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 41:2399–2428CrossRef

Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, Mahiuddin G, Mostofa G, Hsueh YM, Wright RO, Christiani DC (2012) Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect 120:1061–1066CrossRef

Kim YJ, Kim JM (2015) Arsenic toxicity in male reproduction and development. Dev Rep 19:167–180CrossRef

Koedrith P, Kim H, Weon JI, Seo YR (2013) Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity. Int J Hyg Environ Health 216:587–598CrossRef

Komissarova EV, Rossman TG (2010) Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicol Appl Pharmacol 243:399–404CrossRef

Kryeziu K, Pirker C, Englinger B, van Schoonhoven S, Spitzwieser M, Mohr T, Körner W, Weinmüllner R, Tav K, Grillari J, Cichna-Markl M, Berger W, Heffeter P (2016) Chronic arsenic trioxide exposure leads to enhanced aggressiveness via met oncogene addiction in cancer cells. Oncotarget 7:27379–27393

Kundu M, Ghosh P, Mitra S, Das JK, Sau TJ, Banerjee S, States JC, Giri AK (2011) Precancerous and non-cancer disease endpoints of chronic arsenic exposure: the level of chromosomal damage and XRCC3 T241 M polymorphism. Mutat Res 706:7–12CrossRef

Lan CC, Yu HS, Ko YC (2011) Chronic arsenic exposure and its adverse health effects in Taiwan: a paradigm for management of a global environmental problem. Kaohsiung J Med Sci 27:411–416CrossRef

Lee TC, Huang RY, Jan KY (1985) Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat Res 148:83–89CrossRef

Li SZ (1982) The compendium of Materia medica (originally published in the Ming dynasty of China, 1578). People’s Medical Publishing House, Beijing

Lin S, Cullen WR, Thomas DJ (1999) Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem Res Toxicol 12:924–930CrossRef

Lin S, Del Razo LM, Styblo M, Wang C, Cullen WR, Thomas DJ (2001) Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol 14:305–311CrossRef

Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ (2002) A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795–10803.

Lindberg AL, Rahman M, Persson LA, Vahter M (2008) The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol Appl Pharmacol 230:9–16CrossRef

Liu J, Chen B, Lu Y, Guan Y, Chen F (2012) JNK-dependent Stat3 phosphorylation contributes to Akt activation in response to arsenic exposure. Toxicol Sci 29:363–371CrossRef

Liu J, Waalkes MP (2008) Liver is a target of arsenic carcinogenesis. Toxicol Sci 105:24–32CrossRef

Liu ZM, Tseng HY, Cheng YL, Yeh BW, Wu WJ, Huang HS (2015) TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis. Toxicol Appl Pharmacol 285:41–50CrossRef

Loffredo CA, Aposhian HV, Cebrian ME, Yamauchi H, Silbergelda EK (2003) Variability in human metabolism of arsenic. Environ Res 92:85–91CrossRef

Lu K, Abo RP, Schlieper KA, Graffam ME, Levine S, Wishnok JS, Swenberg JA, Tannenbaum SR, Fox JG (2014) Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect 122:284–291

Lu K, Cable PH, Abo RP, Ru H, Graffam ME, Schlieper KA, Parry NM, Levine S, Bodnar WM, Wishnok JS, Styblo M, Swenberg JA, Fox JG, Tannenbaum SR (2013) Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation. Chem Res Toxicol 26:1893–1903CrossRef

Lubin JH, Pottern LM, Stone BJ, Fraumeni JF Jr (2000) Respiratory cancer in a cohort of copper smelter workers: results from more than 50 years of follow-up. Amer J Epidemiol 151:554–565CrossRef

Mann KK, Wallner B, Lossos IS, Miller WH Jr (2009) Darinaparsin: a novel organic arsenical with promising anticancer activity. Expert Opin Investig Drugs 18:1727–1734CrossRef

Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH (2007) Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99:920–928CrossRef

Marsit CJ, Eddy K, Kelsey KT (2006) MicroRNA responses to cellular stress. Cancer Res 66:10843–10848CrossRef

Martinez VD, Vucic EA, Becker-Santos DD, Gil L, Lam WL (2011) Arsenic exposure and the induction of human cancers. J Toxicol 2011:431287CrossRef

Mathews V, George B, Lakshmi KM, Viswabandya A, Bajel A, Balasubramanian P, Shaji RV, Srivastava VM, Srivastava A, Chandy M (2006) Single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood 107:2627–2632CrossRef

Mazumder DN (2005) Effect of chronic intake of arsenic-contaminated water on liver. Toxicol Appl Pharmacol 206:169–175CrossRef

Mead MN (2005) Arsenic: in search of an antidote to a global poison. Environ Health Perspect 113:378–386CrossRef

Melak D, Ferreccio C, Kalman D, Parra R, Acevedo J, Pérez L, Cortés S, Smith AH, Yuan Y, Liaw J, Steinmaus C (2014) Arsenic methylation and lung and bladder cancer in a case control study in northern Chile. Toxicol Appl Pharmacol 274:225–231CrossRef

Méndez-Gómez J, García-Vargas GG, López-Carrillo L, Calderón-Aranda ES, Gómez A, Vera E, Valverde M, Cebrián ME, Rojas E (2008) Genotoxic effects of environmental exposure to arsenic and lead on children in region Lagunera, Mexico. Ann N Y Acad Sci 1140:358–367CrossRef

Milton AH, Hasan Z, Rahman A, Rahman M (2001) Chronic arsenic poisoning and respiratory effects in Bangladesh. J Occup Health 43:136–140CrossRef

Most H (1972) Drug therapy—treatment of common parasitic infection of man encountered in the United States. N Engl J Med 287:698CrossRef

Muenyi CS, Ljungman M, States JC (2015) Arsenic disruption of DNA damage responses-potential role in carcinogenesis and chemotherapy. Biomolecules 5:2184–2193CrossRef

Murai T, Iwata H, Otoshi T, Endo G, Horiguchi S, Fukushima S (1993) Renal lesions induced in F344/DuCrj rats by 4 weeks oral administration of dimethylarsenic acid. Toxicol Lett 66:53–61CrossRef

Naranmandura H, Suzuki N, Suzuki KT (2006) Trivalent arsenicals are bound to proteins during reductive methylation. Chem Res Toxicol 19:1010–1018CrossRef

Naranmandura H, Xu S, Sawata T, Hao WH, Liu H, Bu N, Ogra Y, Lou YJ, Suzuki N (2011) Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity. Chem Res Toxicol 24:1094–1103CrossRef

Nash TA (1960) Review of the African trypanosomiasis problem. Trop Dis Bull 57:973–1013

Nasr R, Rosenwald A, El-Sabban ME, Arnulf B, Zalloua P, Lepelletier Y, Bex F, Hermine O, Staudt L, de Thé H, Bazarbachi A (2003) Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Blood 101:4576–4582CrossRef

Naujokas MF, Anderson B, Ahsan H, Aposhian HV, Graziano JH, Thompson C, Suk WA (2013) The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect 121:295–302CrossRef

Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Guallar E (2005) Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Amer J Epidemiol 162:1037–1049CrossRef

Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E (2008) Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300:814–822CrossRef

Nemeti B, Regonesi ME, Tortora P, Gregus Z (2010) Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP. Toxicol Sci 117:270–281CrossRef

Ng JC, Wang J, Shraim A (2003) A global health problem caused by arsenic from natural sources. Chemosphere 52:1353–1359CrossRef

Nickson R, Sengupta C, Mitra P, Dave SN, Banerjee AK, Bhattacharya A, Basu S, Kakoti N, Moorthy NS, Wasuja M, Kumar M, Mishra DS, Ghosh A, Vaish DP, Srivastava AK, Tripathi RM, Singh SN, Prasad R, Bhattacharya S, Deverill P (2007) Current knowledge on the distribution of arsenic in groundwater in five states of India. J Environ Sci Health 42:1707–1718CrossRef

Nimmanapalli R, Bali P, O'Bryan E, Fuino L, Guo F, Wu J, Houghton P, Bhalla K (2003) Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of bcr-abl levels and apoptosis of human leukemia cells. Cancer Res 63:7950–7958

Nollen M, Ebert F, Moser J, Mullenders LH, Hartwig A, Schwerdtle T (2009) Impact of arsenic on nucleotide excision repair: XPC function, protein level, and gene expression. Mol Nutr Food Res 53:572–582CrossRef

Nriagu JO, Azcue JM (1990) Food contamination with arsenic in the environment. Adv Environ Sci Technol 23:121–143

Osmond MJ, Kunz BA, Snow ET (2010) Age and exposure to arsenic alter base excision repair transcript levels in mice. Mutagenesis 25:517–522CrossRef

Pan C, Zhu D, Zhuo J, Li L, Wang D, Zhang CY, Liu Y, Zen K (2016) Role of signal regulatory protein α in arsenic trioxide-induced promyelocytic leukemia cell apoptosis. Sci Rep 6:23710CrossRef

Papadimitrakopoulou V (2012) Development of PI3K/AKT/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancer. J Thorac Oncol 7:1315–1326CrossRef

Parvez F, Wasserman GA, Factor-Litvak P, Liu X, Slavkovich V, Siddique AB, Sultana R, Sultana R, Islam T, Levy D, Mey JL, van Geen A, Khan K, Kline J, Ahsan H, Graziano JH (2011) Arsenic exposure and motor function among children in Bangladesh. Environ Health Perspect 119:1665–1670CrossRef

Peters BA, Hall MN, Liu X, Slavkovich V, Ilievski V, Alam S, Siddique AB, Islam T, Graziano JH, Gamble MV (2015) Renal function is associated with indicators of arsenic methylation capacity in Bangladeshi adults. Environ Res 143:123–130CrossRef

Qin XJ, Liu W, Li YN, Sun X, Hai CX, Hudson LG, Liu KJ (2012) Poly(ADP-ribose)polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci 127:120–129CrossRef

Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266:4244–4250

Rahman A, Persson LA, Nermell B, El Arifeen S, Ekstrom EC, Smith AH, Vahter M (2010a) Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology 21:797–804CrossRef

Rahman A, Vahter M, Ekstrom EC, Persson LA (2010b) Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect 119:719–724CrossRef

Reichard JF, Puga A (2010) Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2:87–104CrossRef

Ren R (2005) Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5:172–183CrossRef

Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L (2011) An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 119:11–19CrossRef

Rogers EH, Chernoff N, Kavlock RJ (1981) The teratogenic potential of cacodylic acid in the rat and mouse. Drug Chem Toxicol 4:49–61CrossRef

Rosenberg HG (1974) Systemic arterial disease and chronic arsenicism in infants. Arch Pathol 97:360–365

Rossman TG, Klein CB (2011) Genetic and epigenetic effects of environmental arsenicals. Metallomics 3:1135–1141CrossRef

Rossman TG (2003) Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res 533:37–65CrossRef

Saha JC, Dikshit AK, Bandyopadhyay M, Saha KC (1999) A review of arsenic poisoning and its effects on human health. Crit Rev Environ Sci Technol 29:281–313CrossRef

Sanchez TR, Perzanowski M, Graziano JH (2016) Inorganic arsenic and respiratory health, from early life exposure to sex-specific effects: a systematic review. Environ Res 147:537–555.CrossRef

Schwarz RS (2004) Paul Ehrlich’s magic bullets. N Engl J Med 350:1079–1080CrossRef

Shen H, Xu W, Zhang J, Chen M, Martin FL, Xia Y, Liu L, Dong S, Zhu YG (2013) Urinary metabolic biomarkers link oxidative stress indicators associated with general arsenic exposure to male infertility in a Han Chinese population. Environ Sci Technol 47:8843–8851

Shen H, Niu Q, Xu M, Rui D, Xu S, Feng G, Ding Y, Li S, Jing M (2016) Factors affecting arsenic methylation in arsenic-exposed humans: a systematic review and meta-analysis. Int J Environ Res Public Health 13:205CrossRef

Simeonova PP, Luster MI (2002) Arsenic carcinogenicity: relevance of c-Src activation. Mol Cell Biochem 234–235:277–282CrossRef

Smith AH, Ercumen A, Yuan Y, Steinmaus CM (2009) Increased lung cancer risks are similar whether arsenic is ingested or inhaled. J Expo Sci Environ Epidemiol 19:343–348CrossRef

Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT (1992) Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259–267CrossRef

Smith AH, Lingas EO, Rahman M (2000) Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ 78:1093–1103

Smith AH, Marshall G, Yuan Y, Liaw J, Ferreccio C, Steinmaus C (2011) Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Amer J Epidemiol 173:414–420CrossRef

Spivey A (2011) Arsenic and infectious disease: a potential factor in morbidity among Bangladeshi children. Environ Health Perspect 119:218CrossRef

Steinmaus C, Carrigan K, Kalman D, Atallah R, Yuan Y, Smith AH (2005) Dietary intake and arsenic methylation in a U.S. population. Environ Health Perspect 113:1153–1159CrossRef

Stueckle TA, Lu Y, Davis ME, Wang L, Jiang BH, Holaskova I, Schafer R, Barnett JB, Rojanasakul Y (2012) Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol 261:204–216CrossRef

Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ (2002) The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110:767CrossRef

Su CC, Lu JL, Tsai KY, Lian Ie B (2011) Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan. Cancer Causes Control 22:101–108CrossRef

Sung TI, Wang YJ, Chen CY, Hung TL, Guo HR (2012) Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic. Sci Total Environ 424:74–78CrossRef

Tang F, Liu G, He Z, Ma WY, Bode AM, Dong Z (2006) Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells. Mol Carcinog 45:861–870CrossRef

Thomas DJ, Li J, Waters SB, Xing W, Adair BM, Drobna Z, Devesa V, Styblo M (2007) Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med 232:3–13

Thu KL, Pikor LA, Chari R, Wilson IM, Macaulay CE, English JC, Tsao MS, Gazdar AF, Lam S, Lam WL, Lockwood WW (2011) Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF-kappaB pathway activation in lung cancer. J Thor Oncol 6:1521–1529CrossRef

Tseng CH, Chong CK, Chen CJ, Tai TY (1996) Dose–response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in black foot disease endemic villages in Taiwan. Atherosclerosis 120:125–133CrossRef

Tseng WP (1977) Effect of dose-response relationships of skin cancer and Blackfoot disease with arsenic. Environ Health Perspect 19:109–119CrossRef

Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40:453–463

Turrens JF (1997) Superoxide production by the mitochondrial respiratory chain. Biosci Rep 17:3–8CrossRef

Vahter M (2002) Mechanisms of arsenic biotransformation. Toxicology 181:211–217CrossRef

Venkatesan RN, Treuting PM, Fuller ED, Goldsby RE, Norwood TH, Gooley TA, Ladiges WC, Preston BD, Loeb LA (2007) Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol Cell Biol 27:7669–7682CrossRef

Verma A, Mohindru M, Deb DK, Sassano A, Kambhampati S, Ravandi F, Minucci S, Kalvakolanu DV, Platanias LC (2002) Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide. J Biol Chem 277:44988–44995CrossRef

Vogt BL, Rossman TG (2001) Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts—a possible mechanism for arsenite’s comutagenicity. Mut Res 478:159–168CrossRef

Walter I, Schwerdtle T, Thuy C, Parsons JL, Dianov GL, Hartwig A (2007) Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair 6:61–70CrossRef

Waters SB, Devesa V, Del Razo LM, Styblo M, Thomas DJ (2004) Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem Res Toxicol 17:404–409CrossRef

Wang CH, Hsiao CK, Chen CL, Hsu LI, Chiou HY, Chen SY, Hsueh YM, Wu MM, Chen CJ (2007) A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol 222:315–326CrossRef

Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS (2015) Application of metagenomics in the human gut microbiome. World J Gastroenterol 21:803–814CrossRef

Wang Y, Fang J, Leonard SS, Rao KM (2004) Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic Biol Med 36:1434–1443CrossRef

Wang Z, Yang J, Fisher T, Xiao H, Jiang Y, Yang C (2012) Akt activation is responsible for enhanced migratory and invasive behavior of arsenic transformed human bronchial epithelial cells. Environ Health Perspect 120:92–97CrossRef

Wang Z, Zhao Y, Smith E, Goodall GJ, Drew PA, Brabletz T, Yang C (2011) Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol Sci 121:110–122CrossRef

Wang ZY, Chen Z (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111:2505–2515CrossRef

Wei M, Wanibuchi H, Yamamoto S, Li W, Fukushima S (1999) Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20:1873–1876CrossRef

Wen G, Calaf GM, Partridge MA, Echiburu-Chau C, Zhao Y, Huang S, Chai Y, Li B, Hu B, Hei TK (2008) Neoplastic transformation of human small airway epithelial cells induced by arsenic. Mol Med 14:2–10CrossRef

Wiencke JK, Yager JW (1992) Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane. Environ Mol Mutagen 19:195–200CrossRef

Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001–1003CrossRef

Wiwanitkit V (2015) Contamination of arsenic species in rice and the calculation for risk of cancer. J Cancer Res Ther 11:1044CrossRef

Yamamoto S, Konishi Y, Matsuda T, Murai T, Shibata MA, Matsui-Yuasa I, Otani S, Kuroda K, Endo G, Fukushima S (1995) Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res 55:1271–1276

Yamauchi H, Fowler BA (1994) Toxicity and metabolism of inorganic and methylated arsenicals. In: Nriagu JO (ed) Arsenic in the environment, part II: human health and ecosystem effects. Wiley, New York, pp 35–43

Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137CrossRef

Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M, Smith AH (2010) Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology 21:103–108CrossRef

Zachariac H, Sogard H, Nyfors A (1974) Liver biopsy in psoriatic previously treated with potassium arsenite. A controlled study. Acta Derm Venereol 54:235–236

Zhang QY, Mao JH, Liu P, Huang QH, Lu J, Xie YY, Weng L, Zhang Y, Chen Q, Chen SJ, Chen Z (2009) A systems biology understanding of the synergistic effects of arsenic sulfide and imatinib in BCR/ABL-associated leukemia. Proc Natl Acad Sci U S A 106:3378–3383CrossRef

Zhang W, Chen L, Zhou Y, Wu Y, Zhang L (2016) Biotransformation of inorganic arsenic in a marine herbivorous fish Siganus fuscescens after dietborne exposure. Chemosphere 147:297–304CrossRef

Zhang Y, Bhatia D, Xia H, Castranova V, Shi X, Chen F (2006) Nucleolin links to arsenic-induced stabilization of GADD45alpha mRNA. Nucleic Acids Res 34:485–495CrossRef

Zhang Q, Wang D, Zheng Q, Zheng Y, Wang H, Xu Y, Li X, Sun G (2014) Joint effects of urinary arsenic methylation capacity with potential modifiers on arsenicosis: a cross-sectional study from an endemic arsenism area in Huhhot Basin, northern China. Environ Res 132:281–289CrossRef

Zhao Y, Toselli P, Li W (2012) Microtubules as a critical target for arsenic toxicity in lung cells in vitro and in vivo. Int J Environ Res Public Health 9:474–495CrossRef

Zhou G, Zhang J, Wang Z, Chen S, Chen Z (2007) Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Philos Trans Roy Soc B 362:959–971CrossRef

Zhou L, Hou J, Chan CFG, Sze DMY (2014) Arsenic trioxide for non-acute promyelocytic leukemia hematological malignancies: a new frontier. J Blood Disord 1:1018

Zhu J, Chen Z, Lallemand-Breitenbach V, de The H (2002) How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer 2:705–713CrossRef

Ziech D, Franco R, Pappa A, Panayiotidis MI (2011) Reactive oxygen species (ROS)–induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711:167–173CrossRef

Titel: Studies on Arsenic and Human Health
verfasst von: Soumya Chatterjee
Sibnarayan Datta
Dharmendra K. Gupta
Verlag: Springer International Publishing
Buch: Arsenic Contamination in the Environment
Print ISBN: 978-3-319-54354-3

Electronic ISBN: 978-3-319-54356-7

Copyright-Jahr: 2017
DOI: https://doi.org/10.1007/978-3-319-54356-7_3